首页> 外文期刊>PACE: Pacing and clinical electrophysiology >Radiofrequency ablation of the ventricular tachycardia with arrhythmogenic right ventricular cardiomyopathy using non-contact mapping.
【24h】

Radiofrequency ablation of the ventricular tachycardia with arrhythmogenic right ventricular cardiomyopathy using non-contact mapping.

机译:射频消融治疗心律失常性右室心肌病的室性心动过速采用非接触式测绘。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Intracardiac non-contact mapping provides a rapid and accurate isopotential mapping that facilitates catheter ablation of the ventricular tachyarrhythmias in arrhythmogenic right ventricular cardiomyopathy (ARVC). METHODS: Thirty-two consecutive patients (26 men and 6 women, mean 37.2 +/- 13.8 years) were treated with ablation. Fourteen patients had a history of syncope/pre-syncope. Two patients had an implantable cardiac defibrillator (ICD) previously implanted. RESULTS: There were 67 ventricular tachycardias (VTs) induced in the 32 patients. The average VT rate was 210 +/- 32.2 (130-310) bpm. There were 42 episodes of VT that had a heart rate > or =200 bpm and 24 of the 32 patients (75%) had > or =2 morphologies of VT. Regional ablation was applied by targeting the earliest VT activation sites under the guidance of non-contact mapping. Acute success was achieved in 84.4% (27/32) patients, and significant improvement was seen in 15.6% (5/32) patients as evidenced by a slower rate of VT. None of the patients experienced syncope/pre-syncope or sudden death during the 28.6 +/- 16 (9-72) month follow-up. There were no complications of the procedure. At the end of follow-up, 81.3% of the patients were free of VT without medication while the rest of the patients achieved a modified success. CONCLUSIONS: The rapid ventricular tachyarrhythmias in ARVC patients can be abolished or improved significantly by regional RF catheter ablation under the guidance of non-contact mapping. There was no sudden cardiac arrest or death in those patients without ICD implantation. Delayed efficacy may occur in some patients after ablation.
机译:背景:心脏内非接触标测提供了一种快速而准确的等电位标测,有助于在心律失常性右心室心肌病(ARVC)中消融室速。方法:采用消融术治疗了32例连续患者(男26例,女6例,平均37.2 +/- 13.8岁)。 14名患者有晕厥/晕厥前病史。两名患者先前曾植入可植入心脏除颤器(ICD)。结果:32例患者发生67例室性心动过速(VT)。平均室速为210 +/- 32.2(130-310)bpm。心率≥200 bpm的室速发作42例,32例患者中有24例(75%)≥2的室速。在非接触测绘的指导下,通过靶向最早的VT激活部位来应用区域消融。 VT成功率降低证明了84.4%(27/32)的患者获得了急性成功,而15.6%(5/32)的患者则获得了明显的改善。在28.6 +/- 16(9-72)个月的随访期间,没有患者经历晕厥/晕厥前或突然死亡。该手术没有并发症。随访结束时,有81.3%的患者无需药物治疗即可无室速,其余患者则取得了一定的成功。结论:在非接触性测绘的指导下,局部射频导管消融可消除或明显改善ARVC患者的快速心律失常。没有植入ICD的患者没有心脏骤停或死亡。消融后某些患者可能出现疗效延迟。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号